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Implication for health policy/practice/research/medical education: {#key1}
==================================================================

According to the considerable effect of isotonic saline on hyponatremic patients, it seems that administering isotonic fluids regardless of the types of dysnatremia can be recommended to lessen clinicians' conflicting decision making in selecting an appropriate fluid at the commence of treatment in patients with gastroenteritis (GE).

Introduction {#s1}
============

Gastroenteritis (GE) is one of the most common pediatric diseases and dehydration induced by it can cause mortality and morbidity in developing countries ([@R1]). Although, oral rehydration therapy (ORT) is the first step for treating patients. However, intravenous (IV) fluids should be indicated when oral therapy cannot be tolerated ([@R2]). Administering IV hypotonic saline as maintenance and fluid loss is still one of the most common methods of GE treatment ([@R3]).

But, investigations mentioned that hyponatremia commonly occurs by administering hypotonic fluids to GE ([@R4]) and hospitalized children ([@R5],[@R6]). Hyponatremia (plasma sodium less than 135 mmol/L) has been known as a cause of morbidity and mortality in hospitalized children ([@R7]). It can induce cerebral hernia, convulsion, respiratory arrest, pulmonary edema and irreversible neurologic sequelae ([@R8]). The release of antidiuretic hormone (ADH) as a result of non-osmotic stimulus such as nausea, vomiting, ache, tension, trauma, and opioids is the main common cause of hyponatremia in hospitalized children ([@R9]). Therefore, investigators declared using isotonic saline as the routine maintenance solution for GE patients ([@R10]-[@R13]).

As, there is no consensus on the ideal method of treatment, we aimed to assess suitable IV fluid for preventing dysnatremia in children with GE.

Patients and Methods {#s2}
====================

This is a double blind randomized clinical trial, which was conducted on 6 months infants up to 14 years children admitted in 17 Shahrivar Children's hospital in Rasht, north of Iran during January 2013 to April 2014. Patients with GE and inability to tolerate ORT, lack of any known confounding diseases such as abnormality of ADH secretion, pituitary or hypothalamic diseases, renal diseases, acute or chronic lung disease and no previous and/or recent usage of ADH stimulating secretion drugs were included to the study. During study protocol, patients with loss of consciousness, toxicity and anemia were excluded. Informed consents were obtained from parents and children were randomly assigned by blocking in two different groups and matched based on degree of dehydration. Group A received 20 cc/kg 0.9% isotonic saline solution as a bolus as needed and 5% dextrose in hypotonic saline solution (0.45%) with 20 mEq/L KCL as sum of maintenance fluid and volume deficit. Group B was treated with 20 cc/kg 0.9% isotonic saline solution as a bolus as needed and 5% dextrose in isotonic saline solution (0.9%) with 20 mEq/L KCL as sum of maintenance fluid and volume deficit ([Figure 1](#F1){ref-type="fig"}).
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The daily water requirements for treatment indicated based on weight and the slow replacement protocol was used for infusion. Blood samples were taken at admission (T0), 4 (T4) and 24 (T24) hours after commencing IV therapy for measuring levels of sodium, potassium, BUN, creatinine, PH, PCO2 and HCO3. Urine samples were also collected to determine sodium, potassium, creatinine and specific gravity concomitantly with blood samples.

Ethical issues {#s2-0-1}
--------------

The research followed the tenets of the Declaration of Helsinki. Informed consents were obtained from parents and the research was approved by the Ethics Committee of Guilan University of Medical Sciences. This clinical trial had a registration ID of IRCT NO: IRCT201211261545N2 in Iran (<http://en.search.irct.ir/view/11579>).

Statistical analysis {#s2-0-2}
--------------------

Data were analyzed by independent *t* test, Mann-Whitney U test, Friedmann test, chi-square and two tailed repeated measurements in the statistical package for social sciences (SPSS Inc, Chicago, version 19.0 for Windows). Statistical significance considered by *P* value less than 0.05 and 95% CI was noted.

Results {#s3}
=======

This study comprised of 75 patients. Mean age and weight were 36±3.1 months and 12.9±10.6 kg, respectively. The majority of patients (60%) were male. Results showed no significant difference between groups regarding age, sex and weight (*P*\>0.05). All patients had mild to moderate degree of dehydration. Baseline hyponatremia and isonatremia were detected in 24 (31.5%) and 51 patients (67.1%), respectively.

[Table 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} demonstrate serum and urine parameters. Repeated measurement analysis of variance (ANOVA) noted no significant difference in groups A (*P*=0.8) and B (*P*=0.49) regarding mean sodium of T0, T4 and T24. Also, mean sodium between groups based on T0, T4 and T24 mentioned no significant difference (*P*=0.97). Serum parameters in 2 groups were presented in [Table 2](#T2){ref-type="table"}.

###### Serum parameters in two groups at different times

  ---------------- -------------------------------- ------------------------------- ------------ --------------- -------------- -------------
                   **Group A (hypotonic saline)**   **Group B (isotonic saline)**                                               
  **T0**           **T4**                           **T24**                         **T0**       **T4**          **T24**        
  Mean sodium      136.47 ± 4.42                    136 ± 4.7                       136.67±2.3   136.23 ± 3.64   136.39 ± 3.4   136.94±2.75
  Mean potassium   3.9 ± 0.61                       4 ± 0.57                        3.91±0.48    4 ± 0.49        3.9 ± 0.44     3.99±0.51
  Mean BUN         12.19 ± 4.4                      9.63 ± 3.4                      7.37±1.97    11.74 ± 5.1     8.9 ± 3.1      7.17±1.28
  Mean creatinin   0.59 ± 0.01                      0.55 ± 0.09                     0.53±0.08    0.57 ± 0.08     0.55 ± 0.08    0.54±0.08
  Mean PCO2        31.71 ± 5.52                     32.74 ± 5.38                    33.96±5.74   30.84 ± 5.16    31.80 ± 4.35   32.86±4.09
  Mean Hco3        16.99 ± 3.39                     17.47 ± 3.3                     18.99±3.6    16.95 ± 3.66    17.49 ± 2.83   18.95±2.6
  Mean pH          7.33                             7.34                            7.36         7.34            7.35           7.36
  ---------------- -------------------------------- ------------------------------- ------------ --------------- -------------- -------------

Abbreviations: BUN, blood urea nitrogen.

###### Urine parameters in groups

  ------------------ -------------------------------- ------------------------------- --------------- --------------- ---------------- -----------------
                     **Group A (hypotonic saline)**   **Group B (isotonic saline)**                                                    
  **T0**             **T4**                           **T24**                         **T0**          **T4**          **T24**          
  Mean sodium        64.59 ± 42.75                    88.12 ± 59.25                   85.41 ± 39.31   94.05 ± 59.66   119.22 ± 69.61   165.67 ± 164.79
  Mean potassium     29.16 ± 33.50                    21.48 ± 18.95                   20.72 ± 30.52   31.4 ± 24.81    22.43 ± 19.80    15.19 ± 9.26
  Mean creatinine    61.56 ± 154.39                   37.87 ± 35.59                   21.24 ± 22.93   36.51 ± 28.89   25.80 ± 20.73    23.09 ± 16.72
  Specific gravity   1.016 ± 0.009                    1.016 ± 0.009                   1.010 ± 0.005   0.990 ± 0.167   0.987 ± 0.169    0.994 ± 0.13
  ------------------ -------------------------------- ------------------------------- --------------- --------------- ---------------- -----------------

At T0, hyponatremia was noted in 28.9% of group A which reduced to 22.2% at T4 and 12.5% at T24. Results indicated no significant difference in intra-individual times in this group (*P*=0.08). However, 35.1% of participants in group B noted hyponatremia at T0 which reduced to 30.3% at T4 and 15.6% at T24. Friedmann test demonstrated significant difference in intra-individual times in group B (*P*=0.05). No hypernatremia was noted by administering isotonic saline solution ([Table 3](#T3){ref-type="table"}).

###### Dodium status in groups

  ---------------------------- -------------------------------- ------------------------------- ----------- ----------- ----------- -----------
                               **Group A (hypotonic saline)**   **Group B (isotonic saline)**                                       
  **T0**                       **T4**                           **T24**                         **T0**      **T4**      **T24**     
  Serum sodium status, n (%)                                                                                                        
  Hyponatremia                 11 (28.9)                        8 (22.2)                        4 (12.5)    13 (35.1)   10 (30.3)   5 (15.6)
  Isonatremia                  27 (71.1)                        27 (75)                         28 (87.5)   24 (64.9)   23 (69.7)   27 (84.4)
  hypernatremia                0 (0)                            1 (2.8)                         0 (0)       0 (0)       0 (0)       0 (0)
  Total, n (%)                 38 (100)                         36 (100)                        32 (100)    37 (100)    33 (100)    32 (100)
  ---------------------------- -------------------------------- ------------------------------- ----------- ----------- ----------- -----------

Our results showed that after 4 and 24 hours administering isotonic saline solution, the mean plasma sodium differs significantly in baseline hyponatremic group (respectively, *P*=0.025 and *P*=0.000) , however, no significant difference was noted 4 and 24 hours after administering hypotonic saline solution (*P*\>0.05).

Mann-Whitney U test obtained no significant difference in T0, T4 and T24 regarding sodium status (*P*=0.56, p=0.45, *P*=0.72, respectively).

Discussion {#s4}
==========

Substitution of fluids and electrolytes loss is the main method of treatment in patients with GE. Although, ORT is the first step for treating patients with GE; but IV fluids should be indicated when oral therapy cannot be tolerated ([@R2]).

For about 50 years, pediatricians commonly recommended the Holliday and Segar guidelines for administering "maintenance" (IV) fluids ([@R14]). However, investigators demonstrated that hypotonic fluid might cause hyponatremia, which causes morbidity and death in hospitalized children ([@R7]). Therefore, according to previous investigations, administering isotonic saline solution in children admitted to emergency departments had been proposed to eliminate iatrogenic hyponatremia. Yet, there is no consensus on the ideal method of treatment ([@R10]-[@R13]).

Our results indicated administering isotonic saline solution decreased hyponatremia statistically significant which was similar with previous investigations ([@R5],[@R6]). Furthermore, 4 and 24 hours after administering isotonic saline solution, the mean plasma sodium differs significantly in baseline hyponatremic group (*P*=0.025 and *P*=0.000, respectively) nonetheless, no significant difference was noted after 4 and 24 hours after administering hypotonic saline solution (*P*\>0.05).

Results showed the preventive effects of isotonic saline solution in increasing plasma sodium concentration in hyponatremic (high rate of hyponatremia at the admission time) and isonatremic patients, it seems that administering isotonic saline solution might be a suitable fluid regardless of the types of dysnatremia. It can lessen clinicians' conflicting decision-making in selecting an appropriate fluid at the commence of treatment in patients with GE.

Also, no hypernatremia was mentioned in isotonic saline group which was similar with previous results ([@R15],[@R16]).

Our results noted no significant difference between groups regarding mean plasma sodium during periods, which was similar with the results mentioned by recent articles ([@R15],[@R17]). Whereas, Sánchez-Bayle et al noted the use of hypotonic fluid did not increase the risk of hyponatremia in GE patients with mild to moderate dehydration ([@R15]). In addition, Saba et al noted no significant difference regarding the rate of change and absolute change in serum \[Na\] between children with medical illnesses admitted by the emergency department (medical), and children admitted following elective surgery (surgical) ([@R17]). However, previous randomized trials noted significantly greater drops in plasma sodium by administering hypotonic solutions compared with isotonic ones ([@R18]-[@R22]).

The discrepancy between the results of studies mentioned above firstly may be due to the percentage of patients' dehydration status. While in our study and the study by Sánchez-Bayle et al, patients in both groups had mild to moderate degrees of dehydration which could not stimulate volume dependant ADH secretion ([@R15]) and secondly, it may be due to less nonosmotic stimuli of ADH secretion in GE than surgery and critical care wards.

Conclusion {#s5}
==========

According to the considerable effect of isotonic saline on hyponatremic patients, it seems that administering isotonic fluids regardless of the types of dysnatremia can be recommended to lessen clinicians' conflicting decision making in selecting an appropriate fluid at the commence of treatment in patients with GE.

Limitations of the study {#s6}
========================

Although, results mentioned significant effect of isotonic saline on hyponatremic patients, it seems that further investigations on more patients can offer new insights to treat patients with GE.
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